Spravato a mind-altering medication related to the club drug Special K, won US approval. Photo: AP

FDA approves Spravato, a fast-acting, Ketamine-like nasal spray to treat people with severe depression

  • The spray acts within hours, rather than weeks or months as is typical for current antidepressants
  • According to the World Health Organisation, some 300 million people around the world suffer from depression
Topic |   Health and wellness

TOP PICKS

Spravato a mind-altering medication related to the club drug Special K, won US approval. Photo: AP
READ FULL ARTICLE